Recent Xarelto News

The Xarelto Lawsuit In Arkansas For Internal Bleeding Injuries

What Is Xarelto?

Xarelto or Rivaroxaban, is one of the latest blood thinners available on the market. Xarelto is an oral drug that is produced by Bayer and Johnson & Johnson. The purpose of blood thinners is to stop serious blood clots from occurring that can obstruct blood from flowing to vital organs. Other blood thinners, also known as anticoagulants need doctors to specifically calculate the correct dosage for each individual patient, whereas with Xarelto only one uniform dosage per patient is required, which is why these types of new blood thinners have garnered such favor with patients and doctors.

The Food and Drug Administration (FDA) endorsed Xarelto to be used by patients who have had a hip or knee replacement procedure in order to cut the risk of blood clot formation, as well as to reduce the possibilities of a stroke occurring in persons with Atrial Fibrillation (AFifb). A rushed decision by the FDA further led to Xarelto being approved for the overall treatment of DVT and PE.

Xarelto’s Market Presence

Xarelto works much like its rival drug Pradaxa, in that they both inhibit thrombin in order to prevent coagulation. Xarelto obstructs Factor Xa which is a protein that aides the coagulation process, and also stops thrombin from forming. Pradaxa works by directly stopping the formation of thrombin.

Xarelto being a new blood thinner is good for its manufacturers because the anticoagulant market is worth a booming $10 billion. Needless to say many organizations want to be a part of this market. The anticoagulant market was previously dominated by the drug Warfarin which requires numerous individual blood tests, lifestyle, and dietary changes in order to come up with the correct dosage for each patient. Blood thinners like Xarelto have proven to be a more convenient option for blood thinner users.

These new blood thinners do not come cheap in comparison to the older version of Warfarin. Xarelto can set a patient back roughly $3,000 annually, in comparison to Warfarin which costs $200. The difference is that Warfarin requires more upkeep in comparison to Xarelto that has one dose with no incessant medical checkups.

As convenient as new blood thinners like Xarelto are, they come with dangerous adverse effects.

The Effects Xarelto Has Been Known To Have

Like all blood thinners there is a risk of bleeding. The same is true of Xarelto and there is the chance that a patient taking Xarelto will suffer uncontrollable bleeding. When this uncontrollable internal bleeding  takes place close to major organs like the brain, kidneys or lungs, there is an interruption of blood flow to that particular organ that causes the organ to lose some or all its ability to function at optimal levels.

There is also a very high chance that there will be pools of blood that form in the body causing other serious health risks. If any injury happens that causes serious bleeding and the blood needs to clot again, the solution is not so simple for a Xarelto patient because there is no reversal antidote. Click here for more information about Xarelto side effects.

What Are The Plausible Numbers Of People Affected By Xarelto In Arkansas?

As already mentioned here, Xarelto is a highly attractive leading blood thinner option due to its low maintenance. As such there have been as many as 11 million prescriptions that have been written for many Americans. To find out the plausible number of people who have had internal bleeding incidents in Arkansas, we used a comparative calculation that allowed us to compare Arkansas’ population compared to the sum total population of America and worked out that 102,289 people were and or are currently using Xarelto in Arkansas.

Furthermore, stats from a Rocket AF study show that there is a 1.7% possibility of severe bleeding in people who are using Xarelto. Using this information, we estimate that 1,739 people have experienced grave internal bleeding injuries because of Xarelto in Arkansas. We also calculated the plausible number of people affected by Xarelto in Arkansas five principal cities.

Arkansas Five Principal Cities

  • Little Rock- 197,706 population
  • Fort Smith- 87,351 population
  • Fayetteville- 80,621 population
  • Springdale- 76,565 population
  • Jonesboro- 72,210 population

Plausible Number Of People Affected By Xarelto In Arkansas

  • Little Rock- 116
  • Fort Smith- 51
  • Fayetteville- 47
  • Springdale- 45
  • Jonesboro- 42

What Are The Steps To Take To File A Lawsuit?

If upon reading this information you believe that you may have a Xarelto lawsuit on your hands, we encourage you to get in touch with our Xarelto advocates as soon as possible to file your lawsuit. If you or someone dear to you took Xarelto and had internal bleeding injuries that led to a stroke, heart attack, abdominal bleeding and more, it is very likely you qualify for a Xarelto settlement.

If you are not sure whether or not you have a lawsuit, do not hesitate to get in touch with us either way, as we can help clarify some questions you have.

For details about getting in touch with us, please go here.

Leave a Reply

Call Now Button